Furthermore, according to the differential analysis of TCGA cohort, the GSEA results indicated that myc targets, allograft rejection, apical junction, hypoxia, and PI3K/Akt/mTOR signaling pathway were significantly enriched in high-risk AML samples. The gene discussed is MYC; the disease is acute myeloid leukemia.